{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:00:39Z","timestamp":1789376439149,"version":"build-2803163510"},"reference-count":38,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T00:00:00Z","timestamp":1278374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal Cellular Physiology"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>TM601 is a synthetic polypeptide with sequence derived from the venom of the scorpion <jats:italic>Leiurus quinquestriatus<\/jats:italic> that has anti\u2010neoplastic activity. It has recently been demonstrated to bind annexin A2 on cultured tumor and vascular endothelial cells and to suppress blood vessel growth on chick chorioallantoic membrane. In this study, we investigated the effects of TM601 in models of ocular neovascularization (NV). When administered by intraocular injection, intravenous injections, or periocular injections, TM601 significantly suppressed the development of choroidal NV at rupture sites in Bruch's membrane. Treatment of established choroidal NV with TM601 caused apoptosis of endothelial cells and regression of the NV. TM601 suppressed ischemia\u2010induced and vascular endothelial growth factor\u2010induced retinal NV and reduced excess vascular permeability induced by vascular endothelial growth factor. Immunostaining with an antibody directed against TM601 showed that after intraocular or periocular injection, TM601 selectively bound to choroidal or retinal NV and co\u2010localized with annexin A2, which is undetectable in normal retinal and choroidal vessels, but is upregulated in endothelial cells participating in choroidal or retinal NV. Intraocular injection of plasminogen or tissue plasminogen activator, which like TM601 bind to annexin A2, also suppressed retinal NV. This study supports the hypothesis that annexin A2 is an important target for treatment of neovascular diseases and suggests that TM601, through its interaction with annexin A2, causes suppression and regression of ocular NV and reduces vascular leakage and thus may provide a new treatment for blinding diseases such as neovascular age\u2010related macular degeneration and diabetic retinopathy. J. Cell. Physiol. 225: 855\u2013864, 2010. \u00a9 2010 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jcp.22296","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T07:28:12Z","timestamp":1278487692000},"page":"855-864","source":"Crossref","is-referenced-by-count":26,"title":["Agents that bind annexin A2 suppress ocular neovascularization"],"prefix":"10.1002","volume":"225","author":[{"given":"Raquel","family":"Lima e Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jikui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan Yuan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean F.","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamala","family":"Kesavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas B.","family":"Jacoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Campochiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,15]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062655"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-1494"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"21198","DOI":"10.1016\/S0021-9258(17)31948-8","article-title":"An endothelial cell receptor for plasminogen and tissue plasminogen activator. II. Annexin II\u2010mediated enhancement of t\u2010PA\u2010dependent plasminogen activation","volume":"269","author":"Cesarman GM","year":"1994","journal-title":"J Biol Chem"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1993.264.2.C361"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M408078200"},{"key":"e_1_2_6_7_1","doi-asserted-by":"crossref","first-page":"21191","DOI":"10.1016\/S0021-9258(17)31947-6","article-title":"An endothelial cell receptor for plasminogen and tissue plasminogen activator. I. Identity with annexin II","volume":"269","author":"Hajjar KA","year":"1994","journal-title":"J Biol Chem"},{"key":"e_1_2_6_8_1","first-page":"580","article-title":"Imaging glioma extent with 131I\u2010TM\u2010601","volume":"46","author":"Hockaday DC","year":"2005","journal-title":"J Nucl Med"},{"key":"e_1_2_6_9_1","first-page":"39","article-title":"Potent pleiotropic anti\u2010angiogenic effects of TM601, a synthetic chlorotoxin peptide","volume":"30","author":"Jacoby DB","year":"2010","journal-title":"Anticancer Res"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.066092"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1984.01040030398010"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(92)31871-8"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-7359com"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI19684"},{"key":"e_1_2_6_15_1","first-page":"4730","article-title":"Multiple forms of angiostatin induce apoptosis in endothelial cells","volume":"92","author":"Lucas R","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.4569"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61697-5"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.05.055"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.06.068"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.04.030"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.04.023"},{"key":"e_1_2_6_22_1","first-page":"281","article-title":"Transgenic mice with increased expression of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization","volume":"151","author":"Okamoto N","year":"1997","journal-title":"Am J Pathol"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90200-3"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2470321"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2006.00736.x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10246"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161207782794167"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2006.03.002"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-004-0890-4"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0113"},{"key":"e_1_2_6_31_1","first-page":"133","article-title":"Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno\u2010associated virus vector","volume":"13","author":"Shyong M\u2010P","year":"2007","journal-title":"Mol Vis"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(04)00297-2"},{"key":"e_1_2_6_33_1","first-page":"101","article-title":"Oxygen\u2010induced retinopathy in the mouse","volume":"35","author":"Smith LEH","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_34_1","first-page":"4871","article-title":"Use of chlorotoxin for targeting of primary brain tumors","volume":"58","author":"Soroceanu L","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_6_35_1","first-page":"180","article-title":"Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors","volume":"39","author":"Tobe T","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65753-7"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1006\/mvre.2002.2444"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(97)00456-9"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-099283"}],"container-title":["Journal of Cellular Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcp.22296","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcp.22296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T16:54:03Z","timestamp":1696870443000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcp.22296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1002\/jcp.22296"],"URL":"https:\/\/doi.org\/10.1002\/jcp.22296","archive":["Portico"],"relation":{},"ISSN":["0021-9541","1097-4652"],"issn-type":[{"value":"0021-9541","type":"print"},{"value":"1097-4652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}